Clinical Trials on Diabetic Complications Neurological
Total 0 results
Nothing found
Sponsors and Collaborators
- European Network For Smoking and Tobacco Prevention
- CTC Bio, Inc.
- The Third Hospital of Changsha
- Marilia Medicine School
- Ionis Pharmaceuticals
- Health Parametrics Inc.
- Zahra Rabbani Khah
- Wushan County People's Hospital
- Mitchell Scheiman
- Northern California Melanoma Center
- Honda R and D Americas, Inc.
- MingSight Pharmaceuticals Pty Limited
- Montreal Neurological Institute and Hospital
- Jeffrey Rudolph
- Jeffrey W. Clark, MD
- Medtronic Atrial Fibrillation Solutions
- John Granton
- Rex Bionics Plc
- Kawin Technology Share-holding Co., Ltd.
- New York State Health Foundation
- View Full List
Medical Conditions
- Brain MRI
- HDT-AHCT
- Pregnancy-Related Condition, Unspecified
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Periferal Arterial Occlusive Disease, PAOD
- Fasting, Diet, Chemotherapy, Toxicity
- Advanced Esophageal Cancers
- H.Pylori Infection
- Ascaris Suum
- Liver Hemangioma
- ACTH-Secreting Pituitary Adenoma
- Renal Cancer Metastatic
- Pancreatic Neoplasms
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- Waldenstrom's Macroglobulinemia Recurrent
- LSIL
- Locally Advanced NSCLC
- Primary Generalized Dystonia
- Metastatic Spine Lesions
- Hyperthyroidism, Autoimmune
- View Full List
Drug Interventions
- Ombrabulin (AVE8062)
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- ESK981
- Fludarabine
- Nimotuzumab
- Postoperative analgesia management
- 5-Fluoro-3-Pyridinecarboxylic Acid
- Pentostatin
- CKD-519
- Levcromakalim
- Bendamustine
- AZD7798
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Toripalimab plus Anlotinib
- Rifaximin
- Levobupivacaine, clonidine
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- 200 µg doxorubicin-containing MNA
- Hydroxychloroquine
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Armenia
- Contract Research Organizations in Australia
- Contract Research Organizations in Croatia
- Contract Research Organizations in Denmark
- Contract Research Organizations in Georgia
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Serbia
- Contract Research Organizations in South Africa
- Contract Research Organizations in South Korea
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Uganda
- CRO list by country